Cart
sales@molnova.com
Proadrenomedullin (45-92), human
CAS No. 166798-69-2
Proadrenomedullin (45-92), human( —— )
Catalog No. M30187 CAS No. 166798-69-2
Proadrenomedullin (45-92), human, a mid-regional fragment of proadrenomedullin (MR-proADM), comprises amino acids 45–92 of pre-proADM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameProadrenomedullin (45-92), human
-
NoteResearch use only, not for human use.
-
Brief DescriptionProadrenomedullin (45-92), human, a mid-regional fragment of proadrenomedullin (MR-proADM), comprises amino acids 45–92 of pre-proADM.
-
DescriptionProadrenomedullin (45-92), human, a mid-regional fragment of proadrenomedullin (MR-proADM), comprises amino acids 45–92 of pre-proADM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number166798-69-2
-
Formula Weight5114.76
-
Molecular FormulaC215H359N67O73S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Glu}{Leu}{Arg}{Met}{Ser}{Ser}{Ser}{Tyr}{Pro}{Thr}{Gly}{Leu}{Ala}{Asp}{Val}{Lys}{Ala}{Gly}{Pro}{Ala}{Gln}{Thr}{Leu}{Ile}{Arg}{Pro}{Gln}{Asp}{Met}{Lys}{Gly}{Ala}{Ser}{Arg}{Ser}{Pro}{Glu}{Asp}{Ser}{Ser}{Pro}{Asp}{Ala}{Ala}{Arg}{Ile}{Arg}{Val}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Lorubbio M, et al. Midregional pro-adrenomedullin (MR-ProADM) reference values in serum. Clin Biochem. 2018 Mar;53:173-174.
molnova catalog
related products
-
CNP (1-22), human
C-Type Natriuretic Peptide (CNP) (1-22), human is the 1-22 fragment of C-Type Natriuretic Peptide.
-
11-Oxomogroside II A...
11-Oxomogroside II A1 (compound 7) is an oxidized cucurbitin. It can be isolated from the ethanol extract of Rohanberry fruit.
-
Saikosaponin C
Saikosaponin C efficiently inhibited LPS-induced apoptotic cell death via inhibition of caspase-3 activation and caspase-3-mediated-FAK degradation.
